Jeffrey Points Buys 1,600 Shares of Shoulder Innovations (NYSE:SI) Stock

Key Points

• Jeffrey Points, CFO of Shoulder Innovations, purchased 1,600 shares of the company stock at an average price of $15.67 per share, totaling approximately $25,072, increasing his holdings to 52,445 shares worth around $821,813.
• The stock of Shoulder Innovations experienced a recent decline, trading at $14.97 with a market capitalization of $227.99 million and a price-to-earnings ratio of -0.50.
• Recent analyst upgrades include moving Shoulder Innovations to a "hold" rating, with price targets set by various firms, averaging $19.60 and indicating a consensus rating of "Moderate Buy".

Shoulder Innovations, Inc. (NYSE:SI - Get Free Report) CFO Jeffrey Points bought 1,600 shares of Shoulder Innovations stock in a transaction dated Friday, September 12th. The stock was acquired at an average cost of $15.67 per share, with a total value of $25,072.00. Following the completion of the acquisition, the chief financial officer directly owned 52,445 shares of the company's stock, valued at approximately $821,813.15. The trade was a 3.15% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website.

Shoulder Innovations Stock Performance

Shares of NYSE:SI traded down $0.74 on Monday, reaching $14.97. The company's stock had a trading volume of 78,248 shares, compared to its average volume of 173,990. Shoulder Innovations, Inc. has a 52-week low of $11.75 and a 52-week high of $17.94. The stock has a market capitalization of $227.99 million and a price-to-earnings ratio of -0.50.

Analyst Ratings Changes

Several research analysts have weighed in on the stock. Wall Street Zen upgraded shares of Shoulder Innovations from a "sell" rating to a "hold" rating in a research report on Saturday. Zacks Research raised shares of Shoulder Innovations to a "hold" rating in a research note on Tuesday, August 26th. Piper Sandler assumed coverage on shares of Shoulder Innovations in a research note on Monday, August 25th. They issued an "overweight" rating and a $18.00 target price on the stock. Morgan Stanley assumed coverage on shares of Shoulder Innovations in a research note on Monday, August 25th. They set an "overweight" rating and a $18.00 price target on the stock. Finally, The Goldman Sachs Group initiated coverage on shares of Shoulder Innovations in a research note on Monday, August 25th. They set a "buy" rating and a $20.00 price target on the stock. Five analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $19.60.

Shoulder Innovations Company Profile

We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. These systems are a core element of our ecosystem, which we designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.